Panelists discuss how the field aims to translate lessons learned from metastatic treatment into earlier-stage interventions for select patients, sharing their current practices and hopes for future advancements in care.
How are we going to address this as a field as to moving what we have learned from the metastatic space to earlier stages for the small subset of patients? What do you do in your practice and what do you hope for in the future?